Company: ARTL
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0001640334-25-001062
Chunk: 0

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-06-26
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry Into a Material Definitive Agreement.

On June 24, 2025, Artelo Biosciences, Inc. (the “ Company”) entered into a securities purchase agreement (the “ Purchase Agreement”) with the purchasers named therein (the “ Purchasers”), for the private placement (the “ Private Placement”) of (i) 136,843 shares (the “ Shares”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock”), at $5.82 per share, (ii) pre-funded warrants to purchase 93,180 shares of Common Stock at an exercise price of $0.001 per Share (the “Pre-Funded Warrants”), (iii) warrants to purchase 460,046 shares of Common Stock at an exercise price of $5.82 per share (the “$5.82 Warrants”), and (ii) warrants to purchase 230,023 shares of Common Stock at an exercise price of $10.00 per share (the “$10.00 Warrants”). The Pre-Funded Warrants, the $5.82 Warrants and the $10.00 Warrants are collectively referred to herein as the “ Warrants” and the shares issuable upon such Warrants, the “ Warrant Shares.”

Each Share or, at the election of the Purchaser in lieu of Shares, each Pre-Funded Warrant, was issued and sold along with two (2) $5.82 Warrants and one (1) $10.00 Warrant. The combined purchase price for the securities was (i) $6.195 per Share of Common Stock and three accompanying Warrants and (ii) $6.194 per Pre-Funded Warrant and three accompanying Warrants. The Private Placement is expected to close on June 26, 2025 (the “Closing Date”), subject to customary closing conditions.

The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full, subject to the Beneficial Ownership Limitation described below. The $5.82 Warrants and $10.00 Warrants are exercisable immediately and have a term of exercise equal to five (5) years from the Closing Date, subject to the Beneficial Ownership Limitation described below.

The Warrants may only be exercised on a cashless basis if there is no registration statement registering, or the prospectus contained therein is not available for, the